H15.029
Brawny scleritis, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Brawny scleritis is a serious inflammatory condition affecting the sclera, the white part of the eye. When it is classified as 'unspecified eye,' it indicates that the precise eye involved has not been detailed. This condition can cause significant discomfort and potential vision problems if not properly managed. Recognizing the symptoms and understanding the potential causes are crucial steps in seeking appropriate care.
Causes & Symptoms
Clinical Causes: Autoimmune diseases (such as rheumatoid arthritis or lupus) Infections (including bacterial, viral, or fungal infections) Trauma or injury to the eye Vascular diseases that affect blood vessels in the eye Idiopathic causes (where the exact cause cannot be determined)
Key Symptoms: Severe eye pain, often deep and aching Redness spreading across the sclera Tenderness upon touch or eye movement Reduced vision or visual disturbances Swelling of the eye
Diagnostic & Treatment
Diagnosis Path: Diagnosing brawny scleritis involves a comprehensive eye examination by an ophthalmologist. The specialist will assess the eye for signs of inflammation, redness, and tenderness. Additional diagnostic tools may include slit-lamp examination, blood tests to detect underlying autoimmune conditions, and imaging studies such as ultrasound or MRI if needed. Since the condition can mimic other eye diseases, thorough evaluation is essential for an accurate diagnosis.
Treatment Protocols: Management of brawny scleritis generally involves reducing inflammation and treating any underlying causes. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is H15.029 a billable ICD-10 code?
Yes, H15.029 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.029?
Clinical documentation must specify the nature of Brawny scleritis, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference